Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled,…

By A. Blauvelt, M. Bruin-Weller, M. Gooderham, J. Cather, J. Weisman, D. Pariser, E. Simpson, K. Papp, H. Hong, Diana Rubel and 20 more. The Lancet, 2017

934 citations recorded by the source corpus.

Subfields: Dermatology, Immunology and Allergy, Physiology

View Paper: https://www.semanticscholar.org/paper/c6286e3319b858312d165c20801e9e691e7e3dce